블로그
-
피부암(기저세포암)을 이버멕틴으로 치료하다 (X 2026.7.26)
"There's a spot on my arm. The doctor says it's cancer. They want to cut it out – but I'm scared."
blog.naver.com · 2026.07.28
-
유방암 치료를 받은 환자에서 동측(치료받은 쪽) 팔의 채혈, 주사, 혈압 측정 및 항공 여행이 림프부종 위험에 미치는 영향
논문 초록 소개 Impact of Ipsilateral Blood Draws, Injections, Blood Pressure Measurements, and Air Travel on the Risk of Lymphedema for Patients Treated for Breast Cancer 유방암 치료를 받은 환자에서 동측(치료받은 쪽) 팔의 채혈, 주사,
blog.naver.com · 2026.07.03
-
민재석 교수, FORS 2026 Best E-Poster Award 수상
민재석 교수는 'Effects of Exercise-Based Prehabilitation on Functional Capacity in Gastrointestinal Cancer
blog.naver.com · 2026.07.03
-
FORS 2026 Best E-Poster Award 수상
민재석 교수는 ‘Effects of Exercise-Based Prehabilitation on Functional Capacity in Gastrointestinal Cancer
blog.naver.com · 2026.07.02
-
Experimental radiation missile' therapy offers hope to children with hard-to-treat cancers
Some children continue to see their cancer progress despite repeated rounds of chemotherapy, radiation National University Hospital(SNUH) has been working with Samsung Medical Center and other institutions on
blog.naver.com · 2026.07.06
-
Beyond Mounjaro: Korean drugmakers chase monthly obesity shot
5형식동사 / 목적격보어 / 병렬 / 명사구 With Eli Lilly’s diabetes and obesity treatment Mounjaro overtaking MSD’s cancer therapy Keytruda as the world’s top-selling drug in the first quarter, Korean drugmakers are focusing on
blog.naver.com · 2026.05.16
-
제임스 반더빅 대장암 사망후 가족 모금
Van Der Beek, who starred as Dawson Leery on the hit WB series “Dawson’s Creek,” died on Feb. 11 following a battle with colorectal cancer.
blog.naver.com · 2026.02.13
-
Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer
, breast cancer is the most prevalent form of a malignant tumour. This is a specific treatment that stops the growth of cancer cells.......
blog.naver.com · 2025.11.02
-
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find ...
resistance and where to find them Abstract CDK4/6 inhibitors (CDK4/6i) have significantly impacted on the treatment of HR + HER2 negative (HER2-) metastatic breast cancer (BC) when combined with endocrine
blog.naver.com · 2025.11.09
-
Impacts of genomic alterations on the efficacy of HER2-targeted antibody–drug conjugates in ...
Impacts of genomic alterations on the efficacy of HER2-targeted antibody–drug conjugates in patients the treatment landscape of metastatic breast cancer.
blog.naver.com · 2025.08.04
